Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Melis M, Tang X-, Attarwala N, Chen Q, Prishker C, Qin L, et al. A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes. Biofactors. 2022;48(2):469-480.

Velu P, Cong L, Rand S, Qiu Y, Zhang Z, Zhang J, et al. Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays. Diagn Microbiol Infect Dis. 2022;104(4):115789.

Szczepanski JM, Hissong E, Manthei DM. Use of Selective Arterial Calcium Stimulation Testing in Identification of Insulinoma in a Patient After Bariatric Surgery. Lab Med. 2022;53(2):e40-e43.

Mukhopadhyay C, Zhou P. G3BP1 modulates SPOP to promote prostate tumorigenesis. Mol Cell Oncol. 2022;9(1):2030171.

Boyraz B, Watkins JC, Soubeyran I, Bonhomme B, Croce S, Oliva E, et al. Cystic Granulosa Cell Tumors of the Ovary: An Analysis of 80 Cases of an Often Diagnostically Challenging Entity. Arch Pathol Lab Med. 2022;146(12):1450-1459.

Brieño-Enriquez MA, Duncan FE, Ghazi A, Klutstein M, Sebastiano V, Tyler J. Editorial: Germ cell development and reproductive aging. Front Cell Dev Biol. 2022;10:1051539.

Sy-Go JP, Herrmann SM, Seshan SV. Monoclonal Gammopathy-Related Kidney Diseases. Adv Chronic Kidney Dis. 2022;29(2):86-102.e1.

Liu D, Rodriguez GD, Zhou H-, Cheng Y-, Li X, Tang W, et al. SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection. Int J Mol Sci. 2022;23(11).

Du W, Adkisson C, Ye X, Duran CL, Selvanesan BC, Gravekamp C, et al. SWIP-a stabilized window for intravital imaging of the murine pancreas. Open Biol. 2022;12(6):210273.

Alnajar H, Ravichandran H, Rendeiro AF, Ohara K, Zoughbi WA, Manohar J, et al. Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab. Cold Spring Harb Mol Case Stud. 2022;8(3).